Method for diagnosis of metabolic bone diseases
CA 2269114 A1 · Owner: Washida, Naohiro · Inventors: Yano, Kazuki; Higashio, Kanji; Washida, Naohiro
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of diagnosing metabolic bone diseases especially, osteoporosis and arthrosis characterized by determining the concentration of osteoclastgenesis inhibitory factor (OCIF) in humor. Monoclonal antibodies recognizing equally both of monomer type and diner type of OCIF. Monoclonal antibodies recognizing selectively diner type of OCIF. And to provide an assay kit for determination of OCIF concentration comprising the aforementioned two antibodies recognizing different epitope of OCIF and having high affinity showing dissociation constant of less than 2 x 10-7 M with antigen. It is useful for a method of diagnosing metabolic bone diseases, especially osteoporosis and arthrosis or for an …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 31, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 31, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 31, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.